MCX shares plunge 8% after Q4 results

MCX shares plummeted 8% to Rs 3,715 in Wednesday's intraday trade on BSE after the company released its quarterly report, which showed positive results but fell below market estimates for the quarter ending March 2024.

Shares of () plunged 8% to Rs 3,715 in Wednesday's intraday trade on BSE following the company's report of positive but below-estimate numbers for the quarter ended March 2024.

Its net profit for the January-March quarter of FY24 stood at Rs 87.8 crore, compared to Rs 5.4 crore in the same period of FY23.

Meanwhile, its operating revenue climbed 35% to Rs 181.14 crore in Q4 against Rs 133.75 crore in the March 2023 quarter. EBITDA came at Rs 120.33 crore in Q4 against Rs 22.15 crore in the corresponding quarter of the previous fiscal.

The MCX saw its margins expand sharply to 56.3% from 1.6% during the same period of the previous fiscal.

Also Read:

The company also declared a final dividend of Rs 7.64 per equity share for FY24.

The recommended dividend will be approved by the shareholders at the 22nd Annual General Meeting. The company is yet to announce the date of the AGM, record date and eligibility of shareholders.

At 11:01 am, the stock was trading 6% lower at Rs 3,787 on BSE. However, the stock has delivered significant returns to its investors, having rallied over 150% in the last one year and more than 170% in the past two years.

Also Read:

As per Trendlyne data, the average target price of the stock is Rs 3,570, which shows a downside potential of 5% from the current market prices. The consensus recommendation from 9 analysts for the stock is a 'Hold'.

In technical terms, the relative strength index (RSI) of the stock is currently at 67.6, signalling it's neither trading in the overbought nor the oversold territory. Additionally, the MACD is at 80.9, which is above its centre and signal line, this is a bullish indicator.

MCX stock stood higher than the 20-day, 30-day, 50-day, 100-day, 150-day and 200-day simple moving averages (SMAs), while lower than 5-day and 10-day SMAs.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)

Source: Stocks-Markets-Economic Times

Останні публікації
Oklo target nearly doubled at Wedbush on AI-driven demand for nuclear energy
24.01.2025 - 18:00
Crypto markets lose steam after Trump's first policy move
24.01.2025 - 18:00
Combination of Google's TPU-DeepMind units may be worth $700 bn - DA Davidson
24.01.2025 - 18:00
British American Tobacco, Altria shares rise after menthol ban proposal dropped
24.01.2025 - 18:00
Morocco stocks higher at close of trade; Moroccan All Shares up 0.34%
24.01.2025 - 18:00
Commerzbank says no talks with UniCredit until specific proposal made
24.01.2025 - 18:00
Venture Global aims for $64 billion valuation at debut in test for energy IPOs
24.01.2025 - 18:00
Intuitive Machines stock surges on NASA contract award
24.01.2025 - 18:00
International Paper's $7.2 billion acquisition of DS Smith gets EU approval
24.01.2025 - 18:00
Short-term stock optimism soars among retail investors, AAII survey shows
24.01.2025 - 18:00
Venture Global shares likely to open up to 6% above IPO price
24.01.2025 - 18:00
Intuitive Surgical, American Express Stir Friday's Market Cap Stock Movers
24.01.2025 - 18:00
BMW joins Chinese EV makers in filing EU court challenge to tariffs
24.01.2025 - 18:00
Turkey stocks lower at close of trade; BIST 100 down 0.08%
24.01.2025 - 18:00
Diageo stock jumps on possible Guinness sale
24.01.2025 - 18:00

© Analytic DC. All Rights Reserved.

new
Аналіз ринку Як вплине завтра звіт NFP на курс долара США?